Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer
Status:
Completed
Trial end date:
2019-02-06
Target enrollment:
Participant gender:
Summary
This study aims to evaluate patients with metastatic castrate-resistant prostate cancer
(mCRPC) undergoing treatment with sipuleucel-T for evidence of treatment-associated immune
activation in lymph nodes and peripheral blood.